Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc, filed a statement of changes in beneficial ownership on August 25, 2026, reporting an acquisition of deferred stock units dated August 21, 2026.

Key Highlights

  • Reporting person: Rajeev A. Modi, identified as an officer with the title Executive Vice President U.S. Pet Health and Global Digital Transformation.
  • Security acquired: 61.6158 deferred stock units in Elanco Animal Health Inc, acquired on August 21, 2026, with a price of $23.97.
  • Post-transaction holdings: Modi beneficially owned 9,770.3122 deferred stock units following the reported transaction, held directly.
  • Unit structure: Each deferred stock unit represents the right to receive one share of company common stock or the cash equivalent, according to the filing.
  • Settlement terms: Units settle in cash or shares following termination of employment or during a specified future year under the Executive Deferral and Stock Match Plan.
  • Issuer and trading symbol: Elanco Animal Health Inc, listed as NYSE:ELAN.

Modi's Deferred Stock Unit Activity Under Elanco's Executive Deferral Plan

According to the filing, Rajeev A. Modi acquired 61.6158 deferred stock units in Elanco Animal Health Inc on August 21, 2026, under transaction code "A" (acquired). The price associated with the transaction was listed as $23.97. Modi serves as Executive Vice President U.S. Pet Health and Global Digital Transformation, a role that places him within the company's leadership for its pet health business segment and digital operations.

The filing notes that each deferred stock unit carries the right to receive one share of Elanco common stock or a cash equivalent. Settlement occurs either following termination of employment or during a specified future year, as governed by Elanco's Executive Deferral and Stock Match Plan. Following the August 21 acquisition, Modi's total direct beneficial ownership of deferred stock units stood at 9,770.3122 units, as reported in Table II of the filing. The form was signed by Amy C. Seidel as Attorney-in-Fact for Rajeev A. Modi and filed on August 25, 2026.

Elanco Animal Health Inc is a company operating in the animal health sector. The filing was submitted as a single-person filing, with Modi identified solely as an officer of the issuer, not as a director or 10% owner.

What Was Disclosed

The filing reported Rajeev A. Modi's acquisition of 61.6158 deferred stock units in Elanco Animal Health Inc on August 21, 2026, at $23.97, bringing his total beneficial ownership of such units to 9,770.3122, held directly under the company's Executive Deferral and Stock Match Plan.